BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14605984)

  • 1. Five years and 4 months of recurrence-free survival in hepatic angiosarcoma.
    Ozden I; Bilge O; Erkan M; Cevikbaş U; Acarli K
    J Hepatobiliary Pancreat Surg; 2003; 10(3):250-2. PubMed ID: 14605984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
    Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
    Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
    Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
    Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
    Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.
    Tralhão JG; Dagher I; Lino T; Roudié J; Franco D
    Eur J Surg Oncol; 2007 Aug; 33(6):746-51. PubMed ID: 17188454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hepatic angiosarcoma: a retrospective analysis of 6 cases.
    Duan XF; Li Q
    J Dig Dis; 2012 Jul; 13(7):381-5. PubMed ID: 22713088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization].
    Harao M; Kotake K; Kojima K; Jindou O; Ishihara M; Matsui T; Hishinuma S; Yamamoto T; Tsukioka T; Igarashi S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2366-9. PubMed ID: 12484076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Hiramatsu N; Hayashi N; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.
    Hamady ZZ; Cameron IC; Wyatt J; Prasad RK; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2006 Jun; 32(5):557-63. PubMed ID: 16580811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis.
    Gomez D; Morris-Stiff G; Wyatt J; Toogood GJ; Lodge JP; Prasad KR
    J Surg Oncol; 2008 Oct; 98(5):371-6. PubMed ID: 18646038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic angiosarcoma of childhood: a case report and review of literature.
    Geramizadeh B; Safari A; Bahador A; Nikeghbalian S; Salahi H; Kazemi K; Dehghani SM; Malek-Hosseini SA
    J Pediatr Surg; 2011 Jan; 46(1):e9-11. PubMed ID: 21238632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.